1963 related articles for article (PubMed ID: 8486420)
1. Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.
Boon T
Int J Cancer; 1993 May; 54(2):177-80. PubMed ID: 8486420
[No Abstract] [Full Text] [Related]
2. Genes coding for antigens recognized on human tumors by autologous cytolytic T lymphocytes.
Coulie P; Weynants P; Muller C; Lehmann F; Herman J; Baurain JF; Boon T
Ann N Y Acad Sci; 1993 Aug; 690():113-9. PubMed ID: 8368730
[No Abstract] [Full Text] [Related]
3. Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T
Biochem Soc Trans; 1995 Aug; 23(3):681-6. PubMed ID: 8566443
[No Abstract] [Full Text] [Related]
4. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
[No Abstract] [Full Text] [Related]
5. Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1.
Marchand M; Brasseur F; van der Bruggen P; Coulie P; Boon T
Dermatology; 1993; 186(4):278-80. PubMed ID: 8513199
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy with MAGE antigens.
Coulie PG
Suppl Tumori; 2002; 1(4):S63-5. PubMed ID: 12415826
[No Abstract] [Full Text] [Related]
7. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395
[TBL] [Abstract][Full Text] [Related]
8. Antigens recognized on human tumors by cytolytic T lymphocytes: towards vaccination?
Coulie PG
Stem Cells; 1995 Jul; 13(4):393-403. PubMed ID: 7549898
[TBL] [Abstract][Full Text] [Related]
9. [Cytotoxic T-cell immune response against melanoma antigens].
Ayyoub M
Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
[No Abstract] [Full Text] [Related]
10. [Rejection antigens of tumors and specific immunotherapy of cancer].
Boon T; Lucas S
Bull Mem Acad R Med Belg; 1996; 151(12):469-79. PubMed ID: 9491625
[TBL] [Abstract][Full Text] [Related]
11. Genes coding for melanoma antigens recognised by cytolytic T lymphocytes.
De Smet C; Lurquin C; De Plaen E; Brasseur F; Zarour H; De Backer O; Coulie PG; Boon T
Eye (Lond); 1997; 11 ( Pt 2)():243-8. PubMed ID: 9349420
[TBL] [Abstract][Full Text] [Related]
12. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
van der Bruggen P; Traversari C; Chomez P; Lurquin C; De Plaen E; Van den Eynde B; Knuth A; Boon T
Science; 1991 Dec; 254(5038):1643-7. PubMed ID: 1840703
[TBL] [Abstract][Full Text] [Related]
13. A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16.
Vantomme V; Boël P; De Plaen E; Boon T; van der Bruggen P
Cancer Immun; 2003 Dec; 3():17. PubMed ID: 14664500
[TBL] [Abstract][Full Text] [Related]
14. Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy.
Krishnadas DK; Wang Y; Sundaram K; Bai F; Lucas KG
Tumour Biol; 2017 Jul; 39(7):1010428317701309. PubMed ID: 28677424
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of T-cell response with a melanoma cell vaccine expressing specific HLA-A antigens.
Hoon DS; Morisaki T; Uchiyama A; Hayashi Y; Foshag LJ; Nizze AJ; Morton DL
Ann N Y Acad Sci; 1993 Aug; 690():343-5. PubMed ID: 8368751
[No Abstract] [Full Text] [Related]
16. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
Kirkin AF; Dzhandzhugazyan K; Zeuthen J
Exp Clin Immunogenet; 1998; 15(1):19-32. PubMed ID: 9619397
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials with VMO for melanoma.
Wallack MK; Sivanandham M
Ann N Y Acad Sci; 1993 Aug; 690():178-89. PubMed ID: 8368736
[No Abstract] [Full Text] [Related]
18. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
Coulie PG; Lehmann F; Lethé B; Herman J; Lurquin C; Andrawiss M; Boon T
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7976-80. PubMed ID: 7644523
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumor-regression antigens in melanoma.
Kawakami Y; Robbins PF; Wang RF; Rosenberg SA
Important Adv Oncol; 1996; ():3-21. PubMed ID: 8791125
[No Abstract] [Full Text] [Related]
20. Defining tumor antigens: mRNA, protein or cytotoxicity?
Lim SH; Periman P; Klug P; Weidanz J; Whitton V; Chiriva-Internati M; Wang Z; Wright S
Trends Immunol; 2002 May; 23(5):236-7; author reply 237-8. PubMed ID: 12102740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
